News
Botanical Solution Inc. and Croda announce their partnership for kilogram quantity production of GMP quality QS-21, an efficacious vaccine adjuvant.
BSI Secures $7 million, totaling over $13 million in Series A funding for development of QS-21 vaccine adjuvant and Quillibrium biofungicide roll out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results